Literature DB >> 8362208

Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease.

S G Lim1, I S Menzies, C A Lee, M A Johnson, R E Pounder.   

Abstract

The relationships among intestinal permeability, advancing human immunodeficiency virus (HIV) infection, and the presence of diarrhoea or weight loss were investigated in 51 HIV patients and 20 healthy controls. Ten patients with untreated coeliac disease were also investigated for comparison. Fasting subjects drank an isosmolar test solution containing D-xylose, lactulose (LL), L-rhamnose (R) and 3-O-methyl-D-glucose. Urine was collected for 5 h, test sugar content being subsequently measured by thin-layer chromatography for the dosing sugars. Intestinal permeability (LL/R excretion ratio) and recovery of D-xylose and 3-O-methyl-D-glucose in urine were abnormal in patients with HIV disease, and especially those with diarrhoea, as they were in coeliac disease. Patients with coeliac disease and HIV disease, especially when diarrhoea and/or weight loss were present, had significantly reduced 5-h excretion of L-rhamnose, D-xylose, and 3-O-methyl-D-glucose. These data indicate that abnormal permeability and reduced intestinal absorption capacity are common in HIV patients, occur at all stages of HIV disease, especially in the presence of diarrhoea, and, with the exception of lactulose permeation, are relatively similar to the alterations seen in coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362208     DOI: 10.3109/00365529309096090

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  20 in total

1.  A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients.

Authors:  N M A Blijlevens; J P Donnelly; A H J Naber; A V M B Schattenberg; B E DePauw
Journal:  Support Care Cancer       Date:  2005-03-15       Impact factor: 3.603

2.  Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea.

Authors:  D Sharpstone; P Neild; R Crane; C Taylor; C Hodgson; R Sherwood; B Gazzard; I Bjarnason
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection.

Authors:  Inderpal Singh; Angela Carville; Saul Tzipori
Journal:  AIDS Res Hum Retroviruses       Date:  2011-03-27       Impact factor: 2.205

4.  Intestinal permeability and inflammation in patients on NSAIDs.

Authors:  G Sigthorsson; J Tibble; J Hayllar; I Menzies; A Macpherson; R Moots; D Scott; M J Gumpel; I Bjarnason
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

5.  Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.

Authors:  Aisha Nazli; Olivia Chan; Wendy N Dobson-Belaire; Michel Ouellet; Michel J Tremblay; Scott D Gray-Owen; A Larry Arsenault; Charu Kaushic
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

6.  Enteric ganglionitis in rhesus macaques infected with simian immunodeficiency virus.

Authors:  Marlene S Orandle; Ronald S Veazey; Andrew A Lackner
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

7.  Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.

Authors:  J Keating; I Bjarnason; S Somasundaram; A Macpherson; N Francis; A B Price; D Sharpstone; J Smithson; I S Menzies; B G Gazzard
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

8.  Measuring mucosal damage induced by cytotoxic therapy.

Authors:  N M A Blijlevens; B van't Land; J P Donnelly; L M'Rabet; B E de Pauw
Journal:  Support Care Cancer       Date:  2004-01-30       Impact factor: 3.603

9.  Lack of interleukin-10-mediated anti-inflammatory signals and upregulated interferon gamma production are linked to increased intestinal epithelial cell apoptosis in pathogenic simian immunodeficiency virus infection.

Authors:  Diganta Pan; Carys S Kenway-Lynch; Wendy Lala; Ronald S Veazey; Andrew A Lackner; Arpita Das; Bapi Pahar
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

10.  Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome.

Authors:  Hervé Trout; France Mentré; Xavière Panhard; Alissi Kodjo; Lélia Escaut; Pascal Pernet; Jean-Gérard Gobert; Daniel Vittecoq; Anne-Laure Knellwolf; Charles Caulin; Jean-François Bergmann
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.